Research suggests that crosslinking lipid nanoparticles can improve the delivery and efficacy of mRNA vaccines. Various studies are exploring different design strategies and techniques, such as reversible post-assembly crosslinking and the use of stimuli-responsive materials, to enhance the delivery of mRNA therapeutics. The applications of these lipid nanoparticles may extend beyond vaccines to other areas, including cancer treatment and targeted delivery to specific cells and tissues.